Search research articles
Contact Us
Filters
Showing results (541-550 of 706) with videos related to
Page
of 71
Sort By:
JAMA Cardiology
|
October 8, 2020
Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis
Darren K McGuire, Weichung J Shih, Francesco Cosentino, et al.
Journal of the American College of Cardiology
|
November 10, 2012
Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction
Andrew N Rassi, Matthew A Cavender, Gregg C Fonarow, et al.
The American Journal of Cardiology
|
September 6, 2011
Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy)
Robert F Storey, Richard C Becker, Robert A Harrington, et al.
JAMA Cardiology
|
November 14, 2019
Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial
Alexander C Fanaroff, Eric D Peterson, Lisa A Kaltenbach, et al.
Clinical Cardiology
|
October 3, 2013
Relationship of race/ethnicity with door-to-balloon time and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: findings from Get With the Guidelines-Coronary Artery Disease
Matthew A Cavender, Andrew N Rassi, Gregg C Fonarow, et al.
Critical Pathways in Cardiology
|
July 30, 2013
Impact of Society of Cardiovascular Patient Care accreditation on quality: an ACTION Registry®-Get With The Guidelines™ analysis
W Frank Peacock, Michael C Kontos, Ezra Amsterdam, et al.
The New England Journal of Medicine
|
October 8, 2010
Clopidogrel with or without omeprazole in coronary artery disease
Deepak L Bhatt, Byron L Cryer, Charles F Contant, et al.
American Heart Journal
|
October 11, 2011
Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome
Michelle L O'Donoghue, Eugene Braunwald, Harvey D White, et al.
American Heart Journal
|
May 16, 2016
Comparison of performance on Hospital Compare process measures and patient outcomes between hospitals that do and do not participate in Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines
Robin Mathews, Gregg C Fonarow, Shuang Li, et al.
American Heart Journal
|
June 15, 2016
Rationale and design of the Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS): A multicenter, cluster-randomized trial of P2Y12 receptor inhibitor copayment reduction after myocardial infarction
Jacob A Doll, Tracy Y Wang, Niteesh K Choudhry, et al.
Page
of 71
Search research articles
Search
Showing results (541-550 of 706) with videos related to
Sort By:
Page
of 71
JAMA Cardiology
|
October 8, 2020
Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis
Darren K McGuire, Weichung J Shih, Francesco Cosentino, et al.
Journal of the American College of Cardiology
|
November 10, 2012
Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction
Andrew N Rassi, Matthew A Cavender, Gregg C Fonarow, et al.
The American Journal of Cardiology
|
September 6, 2011
Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy)
Robert F Storey, Richard C Becker, Robert A Harrington, et al.
JAMA Cardiology
|
November 14, 2019
Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial
Alexander C Fanaroff, Eric D Peterson, Lisa A Kaltenbach, et al.
Clinical Cardiology
|
October 3, 2013
Relationship of race/ethnicity with door-to-balloon time and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: findings from Get With the Guidelines-Coronary Artery Disease
Matthew A Cavender, Andrew N Rassi, Gregg C Fonarow, et al.
Critical Pathways in Cardiology
|
July 30, 2013
Impact of Society of Cardiovascular Patient Care accreditation on quality: an ACTION Registry®-Get With The Guidelines™ analysis
W Frank Peacock, Michael C Kontos, Ezra Amsterdam, et al.
The New England Journal of Medicine
|
October 8, 2010
Clopidogrel with or without omeprazole in coronary artery disease
Deepak L Bhatt, Byron L Cryer, Charles F Contant, et al.
American Heart Journal
|
October 11, 2011
Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome
Michelle L O'Donoghue, Eugene Braunwald, Harvey D White, et al.
American Heart Journal
|
May 16, 2016
Comparison of performance on Hospital Compare process measures and patient outcomes between hospitals that do and do not participate in Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines
Robin Mathews, Gregg C Fonarow, Shuang Li, et al.
American Heart Journal
|
June 15, 2016
Rationale and design of the Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS): A multicenter, cluster-randomized trial of P2Y12 receptor inhibitor copayment reduction after myocardial infarction
Jacob A Doll, Tracy Y Wang, Niteesh K Choudhry, et al.
Page
of 71